RNA, U6 small nuclear 1315, pseudogene (RNU6-1315P)

RNU6-1315P refers to a **pseudogene** of the U6 small nuclear RNA (snRNA) gene family[1][7]. U6 snRNAs are non-coding RNAs crucial for the spliceosome, which catalyzes the removal of introns from precursor mRNA in eukaryotes[3][5]. However, **pseudogenes** like RNU6-1315P are **genomic sequences similar to known functional genes but are non-functional**; they do not produce functional RNA or protein product and instead result from retrotransposition or duplication events[1][7]. U6 pseudogenes are common in vertebrate genomes due to retrotransposition mechanisms mediated by LINE-1 elements, but **RNU6-1315P itself has no known biological activity, function, or therapeutic relevance**[7]. It is not a receptor, enzyme, transporter, or other canonical druggable biological target. Therefore, this "target" is not a true molecular target and should not be considered in drug discovery or therapeutic contexts. **Note:** - This entry is **incorrect as a therapeutic target or receptor** because it does not encode for an active molecule or contribute to known disease or drug mechanisms, nor does it have biomarker or safety concern relevance[1][7]. - Reliable structured biomedical knowledge sources (e.g., GeneCards, NCBI) consistently annotate RNU6-1315P as a pseudogene only[1]. - Alternative names are limited; this specific pseudogene is only referenced with the abbreviation or as a member of the U6 snRNA pseudogene family. **Summary:** RNU6-1315P is a non-functional **pseudogene** of U6 small nuclear RNA, with no established biological, therapeutic, or target significance[1][7].

Other names

RNU6-1315PU6 snRNA pseudogene 1315